This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated KCNE1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-KCNE1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~14.7 kDa | |
| Gel | 15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Glycosylated + Phosphorylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A01229 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | extracts of various cell lines, (catalog A01229) |
| Gel % | 15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.2 µm PVDF (standard starting point) |
| Blocking | Blocking buffer: 3% nonfat dry milk in TBST (catalog A01229) |
| Primary antibody | A01229 · 1:1000 (catalog A01229) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Goat Anti-Rabbit IgG, 1:10000 (catalog A01229) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL (catalog A01229) |
KCNE1 is predicted at 14.7 kDa; its glycosylation sites could affect migration, but no apparent band size or visible shift is demonstrated.
| Band near 14.7 kDa | Consistent with the predicted KCNE1 mass; confirm its identity with controls. |
| Band above 14.7 kDa | Could reflect glycosylation at Asn5, Thr7, or Asn26; the shift is not established. |
| Doublet near the expected region | Could reflect differing glycosylation at the listed sites; confirm both bands are KCNE1. |
| Little or no band in soluble lysate | KCNE1 is a single-pass membrane protein and may be poorly recovered in this fraction. |
| Predicted KCNE1 mass | Places the unmodified protein near 14.7 kDa. |
| N-linked glycosylation at Asn5 | Could increase apparent size; no shift is quantified. |
| O-linked glycosylation at Thr7 | Could affect apparent size; no shift is quantified. |
| N-linked glycosylation at Asn26 | Could increase apparent size; no shift is quantified. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Membrane-localized KCNE1 may be poorly recovered in a soluble fraction. | Check membrane-enriched material and verify extraction with a membrane-protein control. |
| Band higher than expected | Glycosylation at the listed sites could alter migration. | Compare with deglycosylated material and confirm band identity with an independent antibody. |
| Band lower than expected | Glycosylation occupancy may differ from a higher-migrating comparison band. | Compare treated and untreated samples and confirm identity with an independent antibody. |
| Broad smear instead of sharp band | Glycosylation heterogeneity is possible but is not demonstrated by the listed sites alone. | Compare deglycosylated and untreated samples and check loading and transfer. |
| Multiple bands | Different glycosylation states are possible; unrelated antibody binding is also possible. | Compare deglycosylated samples and use KCNE1-depleted material to identify specific bands. |
| Weak or no signal | Recovery of this single-pass membrane protein may be low. | Check membrane extraction, loading, and transfer with appropriate controls. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for KCNE1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A01229 is an anti-KCNE1 antibody listed for human and mouse reactivity. Its WB image is described as using extracts from various cell lines, but the caption does not identify the lines or establish which species were tested.
Which to pick: A01229 is the only listed option and has a WB image. For a starting protocol, the caption reports 25 µg per lane, a 1:1000 primary dilution, and a 90-second exposure.